Hepatocellular carcinoma Circulating tumor cells, liquid biopsy, hepatocellular carcinoma, biomarker
Conditions
Interventions
All patients were received standard of treatment by a multidisciplinary team including hepatologists, surgeons, interventionists, and oncologists and were followed for disease progression and overall
Experimental Procedure/Surgery
Standard treatment
Sponsors
None listed
Eligibility
Sex/Gender
All
Age
18 Years to No maximum
Inclusion criteria
Inclusion criteria: The inclusion criteria were newly diagnosed HCC patients with age more than 18 years. The diagnosis of HCC was defined according to American Association of the Study of Liver Diseases guidelines.
Exclusion criteria
Exclusion criteria: The exclusion criteria were patients with previous or concurrent other malignancies.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Overall survival 3 years Kaplan-Meier method | — |
Secondary
| Measure | Time frame |
|---|---|
| Factors association with survival 3 years Cox proportional hazard analysis | — |
Countries
Thailand
Contacts
Public ContactThaninee Prasoppokakorn
Chulalongkorn University
Outcome results
None listed